The high cost of diagnosing peripheral neuropathy could be greatly reduced if doctors ordered the right tests.…

The FDA Endocrinologic and Metabolic Drugs Advisory Committee voted overwhelmingly (20 to 2) in favor of approving the obesity drug Qnexa (Vivus, Inc.), a combination of phentermine and controlled-release topiramate. Qnexa could be the first prescription drug for obesity to reach the market since 1999.…

An FDA advisory committee’s endorsement of the anti-obesity drug Qnexa could re-energize the pharmaceutical industry after several years of disappointment in trying to develop anti-obesity drugs.…

In a reversal of two decades of medical reports, a Mayo Clinic study finds the frequency of nerve damage called diabetic polyneuropathy is similar in prediabetic patients and healthy people….

A new study contradicts previous studies showing no benefit to self-monitoring for new type 2’s, at least in the first year.…

Brain insulin may act as a satiety signal during the postprandial period and is associated with decreased appetite and reduced intake of highly palatable food….

Short-term treatment with liraglutide improved visceral fat adiposity, appetite, food preference and the urge for fat intake in obese Japanese patients with type 2 diabetes.…

The number of doctors in the US telling patients to get physically active has increased in the past decade. New research shows that, in 2010 alone, one in three patients who visited a physician or other health professional had been told to start or maintain physical activity or exercise.…

A structured course teaching the benefits of automated bolus calculator use and flexible intensive insulin therapy improves metabolic control and satisfaction in patients with type 1 diabetes.…

High intake of flavanones, a subclass of flavonoids found in the greatest concentrations in oranges and grapefruit, is associated with a 19% lower risk for ischemic stroke in women, a new analysis from the Nurses’ Health Study has shown.…